Stay updated with breaking news from Nasdaq Eldn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) saw a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 57,200 shares, a growth of 276.3% from the April 15th total of 15,200 shares. Based on an average daily volume of 122,400 shares, the short-interest ratio is […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) was the recipient of a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 57,200 shares, a growth of 276.3% from the April 15th total of 15,200 shares. Based on an average daily volume of 122,400 shares, the […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) – Stock analysts at SVB Leerink issued their Q1 2023 earnings estimates for Eledon Pharmaceuticals in a research note issued to investors on Tuesday, May 2nd. SVB Leerink analyst T. Smith expects that the company will earn ($0.71) per share for the quarter. The consensus estimate for Eledon […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) was the target of a large decrease in short interest in April. As of April 15th, there was short interest totalling 15,200 shares, a decrease of 47.0% from the March 31st total of 28,700 shares. Approximately 0.1% of the shares of the stock are sold short. Based on […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) saw a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 15,200 shares, a decline of 47.0% from the March 31st total of 28,700 shares. Based on an average daily volume of 26,700 shares, the short-interest ratio is […]